drugset / Trial / NCT00766415

14729-D9831C00002- 1 Month Biopsy Study

NCT00766415

Phase 2 Completed 52 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to study histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

Timeline

Start
2008-11
Primary completion
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule Oral